Authors:
WITTE RS
MANOLA J
BURCH PA
KUZEL T
WEINSHEL EL
LOEHRER PJ
Citation: Rs. Witte et al., TOPOTECAN IN PREVIOUSLY TREATED ADVANCED UROTHELIAL CARCINOMA - AN ECOG PHASE-II TRIAL, Investigational new drugs, 16(2), 1998, pp. 191-195
Authors:
WITTE RS
ELSON P
BONE B
KNOP R
RICHARDSON RR
DREICER R
LOEHRER PJ
Citation: Rs. Witte et al., EASTERN-COOPERATIVE-ONCOLOGY-GROUP PHASE-II TRIAL OF IFOSFAMIDE IN THE TREATMENT OF PREVIOUSLY TREATED ADVANCED UROTHELIAL CARCINOMA, Journal of clinical oncology, 15(2), 1997, pp. 589-593
Authors:
WITTE RS
HSIEH P
ELSON P
OKEN MM
TRUMP DL
Citation: Rs. Witte et al., A PHASE-II TRIAL OF AMONAFIDE, CARACEMIDE, AND HOMOHARRINGTONINE IN THE TREATMENT OF PATIENTS WITH ADVANCED RENAL-CELL CANCER, Investigational new drugs, 14(4), 1996, pp. 409-413
Authors:
WITTE RS
LEONG T
ERNSTOFF MS
KRIGEL RL
OKEN MM
HARRIS J
TORMEY DC
TRUMP DL
Citation: Rs. Witte et al., A PHASE-II STUDY OF INTERLEUKIN-2 WITH AND WITHOUT INTERFERON-BETA INTHE TREATMENT OF ADVANCED RENAL-CELL CARCINOMA, Investigational new drugs, 13(3), 1995, pp. 241-247
Citation: Rs. Witte et al., TRIMETREXATE IN ADVANCED HORMONE-REFRACTORY PROSTATE-CANCER - AN ECOGPHASE-II TRIAL, Investigational new drugs, 12(3), 1994, pp. 255-258
Citation: Rs. Witte et al., AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP PHASE-II TRIAL OF TRIMETREXATE IN THE TREATMENT OF ADVANCED UROTHELIAL CARCINOMA, Cancer, 73(3), 1994, pp. 688-691